These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9288143)

  • 1. Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines.
    Lambert PA; Somers KD; Kohn EC; Perry RR
    Surgery; 1997 Aug; 122(2):372-8; discussion 378-9. PubMed ID: 9288143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
    Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
    Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM; Howard EW; Dmytryk JJ; Pento JT
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of CAI in glioblastoma growth and invasion.
    Jacobs W; Mikkelsen T; Smith R; Nelson K; Rosenblum ML; Kohn EC
    J Neurooncol; 1997 Apr; 32(2):93-101. PubMed ID: 9120549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS; Arand G; Lippman ME; Thompson EW
    J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines.
    Wasilenko WJ; Palad AJ; Somers KD; Blackmore PF; Kohn EC; Rhim JS; Wright GL; Schellhammer PF
    Int J Cancer; 1996 Oct; 68(2):259-64. PubMed ID: 8900438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
    Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
    J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
    Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
    Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
    Kondapaka SB; Fridman R; Reddy KB
    Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays.
    Bae SN; Arand G; Azzam H; Pavasant P; Torri J; Frandsen TL; Thompson EW
    Breast Cancer Res Treat; 1993; 24(3):241-55. PubMed ID: 8435479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.
    Kohn EC; Felder CC; Jacobs W; Holmes KA; Day A; Freer R; Liotta LA
    Cancer Res; 1994 Feb; 54(4):935-42. PubMed ID: 8313384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
    Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
    J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro.
    Rooprai HK; Kandanearatachi A; Rucklidge G; Pilkington GJ
    Ann N Y Acad Sci; 1999 Jun; 878():654-7. PubMed ID: 10415799
    [No Abstract]   [Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 in tumor cell invasion.
    French DL; Ramos-DeSimone N; Rozinski K; Nuovo GJ
    Ann N Y Acad Sci; 1994 Sep; 732():324-34. PubMed ID: 7978802
    [No Abstract]   [Full Text] [Related]  

  • 18. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.
    Ginestra A; La Placa MD; Saladino F; Cassarà D; Nagase H; Vittorelli ML
    Anticancer Res; 1998; 18(5A):3433-7. PubMed ID: 9858920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.
    Winters ME; Mehta AI; Petricoin EF; Kohn EC; Liotta LA
    Cancer Res; 2005 May; 65(9):3853-60. PubMed ID: 15867384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
    Liu H; Zang C; Fenner MH; Possinger K; Elstner E
    Breast Cancer Res Treat; 2003 May; 79(1):63-74. PubMed ID: 12779083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.